Stocks
Amylyx Pharmaceuticals (AMLX) EV/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | -0.88 | 0.30 | 1.16 | -10.5 | 15.6 | 4.62 | |
| Changes by years, y/y, % | -133% | +293% | -1 005% | -248% | ||||
Amylyx Pharmaceuticals. EV/EBITDA
Amylyx Pharmaceuticals. EV/EBITDA, changes, %
Amylyx Pharmaceuticals (AMLX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -10.4 | -13.6 | -123.8 | 15.8 | 2.21 | 4.62 | |
| Changes by years, y/y, % | +240% | +180% | +1 927% | -253% | -121% | |||
| Changes by quarters, q/q, % | +1% | +31% | +809% | -113% | -86% | |||
